Finance

Lists
TVTX:NASDAQ
Travere Therapeutics Inc
US$ ५२.०९
+०.१३%
(+०.०७०) 1D
अक्टोबर १३, ११:२९:४८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TVTX...
Open
US$ ५१.५७
High
US$ ५२.८१
Low
US$ ५१.३८
Mkt. cap
४.९१ अरब
Avg. vol.
१७.२२ लाख
Volume
२.८९ लाख
52-wk high
US$ ६८.७३
52-wk low
US$ २२.५९
EPS
-US$ ०.५०
Beta
१.१३
Shares outstanding
९.४३ करोड
No. of employees
४९७
Open
US$ ५१.५७
High
US$ ५२.८१
Low
US$ ५१.३८
Mkt. cap
४.९१ अरब
Avg. vol.
१७.२२ लाख
Volume
२.८९ लाख
52-wk high
US$ ६८.७३
52-wk low
US$ २२.५९
EPS
-US$ ०.५०
Beta
१.१३
Shares outstanding
९.४३ करोड
No. of employees
४९७
News stories
From web sources and news partners
About Travere Therapeutics Inc
CEO-
Employees४९७
Founded२०११
Headquarters-
Sector-
Websitetravere.com
Analyst ratings
Based on 12 analysts giving stock ratings to TVTX in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for TVTX in the last 3 months.
Highest
Current US$ ५२.०९
US$ ९०.०० (+७२.७८%)
Average
US$ ७५.९२ (+४५.७५%)
Lowest
US$ ६२.०० (+१९.०२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Reiterated
US$ ८९.००
+७०.९%
10/06/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ ६७.००
+२८.६%
10/02/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
US$ ७१.००
+३६.३%
09/23/2026
Laura Chico
Wedbush
Buy
Maintained
US$ ७६.००
+४५.९%
09/22/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
US$ ६८.००
+३०.५%
08/17/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
US$ ७०.००
+३४.४%
08/11/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
US$ ७८.००
+४९.७%
08/10/2026
Alex Thompson CFA
Stifel Nicolaus
Hold
Maintained
US$ ६२.००
+१९%
08/09/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
US$ ९०.००
+७२.८%
08/06/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
US$ ८०.००
+५३.६%
08/06/2026
Yigal Nochomovitz
Citi
Buy
Maintained
US$ ८५.००
+६३.२%
08/06/2026
Tyler Van Buren
TD Cowen
Buy
Reiterated
US$ ७५.००
+४४%
08/04/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ ५०.००
-४%
05/06/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
US$ ५२.००
-०.२%
05/05/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Reiterated
-
-
02/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१६.४९ करोड
१२.९७ करोड
१२.७२ करोड
१६.९६ करोड
Cost of goods sold
५.३५ करोड
६.०४ करोड
८.३९ करोड
६.९५ करोड
Cost of revenue
५.३५ करोड
६.०४ करोड
८.३९ करोड
६.९५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८.६५ करोड
१०.१७ करोड
८.०३ करोड
९.६१ करोड
Operating expense
८.६५ करोड
१०.१७ करोड
८.०३ करोड
९.६१ करोड
Total operating expenses
१३.९९ करोड
१६.२१ करोड
१६.४१ करोड
१६.५६ करोड
Operating income
२.४९ करोड
-३.२४ करोड
-३.६९ करोड
३९.५४ लाख
Other non operating income
४.८७ लाख
१.११ करोड
-९१.०० हजार
-४.०२ करोड
EBT including unusual items
२.५७ करोड
-२.११ करोड
-३.६७ करोड
-३.५० करोड
EBT excluding unusual items
२.५७ करोड
-२.११ करोड
-३.६७ करोड
-३.५० करोड
Income tax expense
८.०० हजार
९.२१ लाख
-१.२० लाख
-२.०४ लाख
Effective tax rate
०.०३%
-४.३७%
०.३३%
०.५८%
Other operating expenses
-
-
-
-
Net income
२.५७ करोड
२७.२९ लाख
-३.७१ करोड
-३.४८ करोड
Net profit margin
१५.५९%
२.१०%
-२९.१७%
-२०.५२%
Earnings per share
०.५९
०.३७
०.०५
-०.१०
Interest and investment income
३०.४७ लाख
२५.९१ लाख
२५.८४ लाख
३३.५६ लाख
Interest expense
-२७.५१ लाख
-२२.९५ लाख
-२३.०० लाख
-२१.३४ लाख
Net interest expenses
२.९६ लाख
२.९६ लाख
२.८४ लाख
१२.२२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
४.०७ करोड
-१.४३ करोड
-१.१७ करोड
८१.८८ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू